Tag: novel agents
- 16/Jan/2026
- by William Womack
-
multiple myeloma
bone disease
novel agents
myeloma bone lesions
denosumab
Multiple Myeloma: Understanding Bone Disease and the Rise of Novel Treatments
Multiple myeloma causes severe bone damage in over 80% of patients. Learn how bone disease develops, why current treatments fall short, and how novel agents like romosozumab and DKN-01 are finally offering hope for healing-not just slowing-bone destruction.
Read
